Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
01/2008
01/31/2008CA2658887A1 Fatty acid amide hydrolase inhibitors
01/31/2008CA2657247A1 Compounds which modulate the cb2 receptor
01/30/2008EP1881827A1 Fused thiazole derivatives as kinase inhibitors
01/30/2008CN101115802A Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element
01/30/2008CN101115748A Acetamide compounds as fungicides
01/30/2008CN101115717A Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
01/30/2008CN100364982C Process for preparing blue light-emitting 2-(2-hydroxy phenyl) benzothiazole chelated beryllium
01/29/2008US7323587 Selective estrogen receptor modulators
01/29/2008US7323573 Production of polyketides
01/29/2008US7323564 Preparation of thiazoles
01/29/2008US7323563 Hydroxamic acid derivatives as antibacterials
01/29/2008US7323484 Farnesyl transferase inhibitors
01/29/2008US7323482 Therapy of p38 kinase-associated conditions; may be useful in treating inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure
01/29/2008US7323456 Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient
01/29/2008CA2383298C New amino acids, their preparation process and pharmaceutical compositions that contain these amino acids
01/29/2008CA2136120C Treatment of incontinence
01/24/2008WO2008011191A1 Antibacterial heterocyclic ureas
01/24/2008WO2008010921A2 Modulators of pharmacokinetic properties of therapeutics
01/24/2008WO2008010315A1 Therapeutic agent for amyotrophic lateral sclerosis
01/24/2008WO2007140439A3 Compounds as cannabinoid receptor ligands and uses thereof
01/24/2008WO2007130075A8 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
01/24/2008WO2007126957A3 New compounds
01/24/2008US20080021221 Method For Producing Aminothiazole Derivative And Production Intermediate
01/24/2008US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay
01/24/2008US20080021077 Bioavailability, nontoxic; 2-(3'-Iodo-4'-aminophenyl)-6-methoxybenzothiazole
01/24/2008US20080021052 Novel glucokinase activators and methods of using same
01/24/2008US20080021005 Pegylated Ion Channel Modulating Compounds
01/24/2008DE102006033572A1 N'-Cyano-N-halogenalkyl-imidamid Derivate N'-cyano-N-haloalkyl-imide amide derivatives
01/24/2008CA2658342A1 Therapeutic agent for amyotrophic lateral sclerosis
01/24/2008CA2653374A1 Modulators of pharmacokinetic properties of therapeutics
01/23/2008EP1880720A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same
01/23/2008EP1879863A1 Amide resorcinol compounds
01/23/2008EP1633354B1 N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes
01/23/2008EP1351945B1 Novel 1,4-diamino-2-(thiazol-2-yl)benzene derivatives and dyes containing said compounds
01/23/2008CN101111486A 抗糖尿病二环化合物 Antidiabetic bicyclic compound
01/23/2008CN101111485A New haloalkylsulfonanilide derivative, herbicide and use method thereof
01/23/2008CN101108834A Method of refining rubber vulcanization accelerant MBT
01/23/2008CN101108833A Tosyl ester substituted benzothiazole derivant and method of synthesizing the same
01/23/2008CN100363362C Thiazole derivatives as NPY receptor antagonists
01/23/2008CN100363361C Hetaryl-substd. heterocycles
01/22/2008US7321063 Sulfonamide inhibitors of aspartyl protease
01/22/2008US7320995 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole
01/22/2008US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
01/17/2008WO2008008718A2 Cyclopentane derivatives as antiglaucoma agents
01/17/2008WO2008008660A2 Cyclopentane derivatives as antiglaucoma agents
01/17/2008WO2008007780A1 Pentadienamide derivative
01/17/2008WO2008006625A2 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
01/17/2008WO2008006257A1 2,4,5-trisubstituted thiazole compounds,preparation methods, pharmaceutical compositions and medical uses thereof
01/17/2008WO2007096647A3 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer
01/17/2008WO2007019080A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
01/17/2008US20080015358 Fluorination Process of Protected Aminothiazole
01/17/2008US20080015253 Peroxisome Proliferator Activated Receptors modulators; ethyl (R,S)-2-(4-trifluoromethylphenyl)oxypent-4-enoate; dyslipidemia, atherosclerosis and diabetes
01/17/2008US20080015219 Treating eye diseases including glaucoma or ocular hypertension; selective prostaglandin EP2 agonists; acid-functional aryl substituted cyclopentanone or hydroxycyclopentane compounds
01/17/2008US20080015216 Histone Deacetylase Inhibitors
01/17/2008US20080015203 Such as 3-[(1S)-2-hydroxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-1,3-thiazol-2-ylbenzamide; glucokinases (Glk)
01/17/2008US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
01/17/2008US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
01/17/2008US20080015192 Inhibitors of polo-like kinases
01/17/2008US20080015190 Inhibitors of Histone Deacetylase
01/17/2008US20080015169 Amino-methyl substituted tetracycline compounds
01/17/2008US20080015157 Novel Water-Soluble Prodrugs
01/17/2008CA2659121A1 Therapeutic compounds
01/17/2008CA2658097A1 Pentadienamide derivatives
01/17/2008CA2657719A1 Cyclopentane derivatives as antiglaucoma agents
01/17/2008CA2657350A1 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
01/16/2008EP1878731A1 Process for producing pramipexole
01/16/2008EP1877406A1 New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
01/16/2008EP1877391A1 Pro-drugs of n-thiazol-2yl-benzamide derivatives
01/16/2008EP1877364A1 Phenylacetylene derivatives having mglur5 receptor affinity
01/16/2008EP1694673B1 Thiazole derivates
01/16/2008EP1644320B1 Indane derivates as muscarinic receptor agonists
01/16/2008CN101107246A Anti-trypanosomiasis agent
01/16/2008CN101106990A Compounds and compositions as protein kinase inhibitors
01/16/2008CN101104598A Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives
01/16/2008CN100361983C Halogen atom-containing bidentate ligand, its iridium complex and electrogenerated phosphorescence device
01/15/2008US7319163 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism
01/15/2008US7319151 (7-benzothiazol-2-yl-9,9-diethyl)fluoren-2-yl-bis(4-crotyloxyphenyl)amine, polymerizable, fluorescence imaging, data storage, eye and sensor protection, microfabrication of microelectromechanical systems (MEMS), photodynamic therapy
01/15/2008US7319150 Method for preparing styryl pyrazole, isoxazole and isothiazole derivatives
01/15/2008US7319104 hPPARs activators
01/15/2008US7319096 Antiarrhythmia agents; liver disorders; skin disorders
01/15/2008US7318966 Luminescent element material and luminescent element comprising the same
01/15/2008CA2210684C Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
01/10/2008WO2007137107A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
01/10/2008WO2007135080A3 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them
01/10/2008WO2007117692A3 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
01/10/2008WO2007093292A3 Insecticidal substituted amino heterocyclic and heteroaryl derivatives
01/10/2008US20080009634 Process for synthesizing beta-lactamase inhibitor intermediates
01/10/2008US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid;
01/10/2008US20080009620 Tricyclic Spacer Systems For Nonlinear Optical Devices
01/10/2008US20080009525 Activator of peroxisome proliferator-activated receptor delta
01/10/2008US20080009520 Benzimidazolidinone derivatives as muscarinic agents
01/10/2008US20080009506 Imidazole Compound
01/10/2008US20080009504 enzyme inhibitors of glucan synthase;1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-3-(acetyloxy)-2-[(2S)-2-amino-2,3-dimethylbutyloxy]-8-[(1R)-1,2-dimethyl propyl]-1,6a,8,10a-tetramethyl-6-oxo-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid
01/10/2008US20080009416 Thiazolium compounds and uses thereof
01/10/2008CA2648520A1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
01/09/2008EP1875915A1 Therapeutic agent for chronic obstructive pulmonary disease
01/09/2008EP1874776A1 Oxazole and thiazole compounds and their use in the treatment of pge2 mediated disorders
01/09/2008EP1874745A1 New 3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands
01/09/2008EP1874744A1 New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
01/09/2008EP1663936B1 Biaryloxymethylarene-carboxylic acids
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 337